查看購物車
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2152877

全球血液學市場，2026-2031年

Worldwide Market for Hematology, 2026-3031
出版日期: | 出版商: Kalorama Information | 英文 75 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

全球實驗室和即時檢測血液學市場預測至2031年

血液常規檢查(CBC) 是醫療機構中最常進行的檢測之一，而用於執行此檢測的設備發展速度甚至超過了檢測本身。血液學是一個成熟的體外診斷 (IVD) 領域，但競爭的焦點不再僅僅集中在細胞計數上。供應商現在競相發展自動化、數位形態測量、人工智慧驅動的細胞分類以及在中心檢查室之外進行 CBC 檢測的能力。 Kalorama Information 的「2026-2031 年全球血液學市場」報告分析了這項變更將如何創造收入，以及哪些供應商能夠抓住這些收入機會。

本報告的主要內容

本報告對全球血液學檢測市場規模及預測進行了分析，並將其分為兩大部門：實驗室血液學檢測和分散式（即時檢測）血液學檢測。實驗室血液學檢測部門的分析依據包括廠商市場佔有率、試劑銷售量（按檢測類型分類）以及地區分佈。分散式血液學檢測部門則分為檢查室級小型設備和手持式設備。此外，本報告也將血紅素和血球容積比檢測與其他在患者附近進行的常規血液學檢測分開分析。

區域分析涵蓋北美、歐洲、亞太地區以及世界其他地區。本報告分別分析了各地區的實驗室檢測和即時檢測銷售額。

科技與市場趨勢

本報告檢驗了影響購買決策的因素，其中包括以下幾點：

  • 數位形態學。本報告探討了從細胞庫系統到全視野塗片成像的過渡，以及遠端閱片在面臨人員短缺的實驗室網路中的作用。
  • 人工智慧在血液學領域的應用包括異常檢測、檢體分流、自動化檢驗和結果時間序列分析。本報告也探討了監管限制和檢驗局限性，這些限制會影響該軟體的快速發展。
  • 分散式檢查。基於試劑盒的緊湊型分析儀使得全血球計數 (CBC) 檢測能夠在腫瘤科診所、急診室和醫生辦公室實施。本報告說明了CLIA 豁免系統與中等複雜程度系統之間的實際差異。
  • 聯合檢測。一些分析儀將單一檢體中的 CBC、CRP、ESR 或 HbA1c 測量結果合併在一起。

競爭分析

本報告提供供應商市場佔有率、公司收入預測，並對實驗室和即時檢測 (POC) 領域的供應商基礎進行層級分析。報告還重點介紹了 Sysmex、Beckman Coulter/Danaher、Mindley、Roche、Siemens Healthineers、Abbott、Horiba 和 Nihon Kohden 等主要公司。

中國專題部分檢驗了集中採購、支付體系改革、進口替代以及國內製造商的崛起。此外，也分析了FDA註冊和CLIA分類的趨勢。產品目錄涵蓋了近期推出的分析儀器、數位形態測量系統、品管產品和即時檢測平台。

調查方法

市場估計和預測以美元計價，數據截至2026年，並包含至2031年的預測。數據基於工廠直銷價，而非零售價或報銷率。市場涵蓋分析儀器、設備、試劑、部分臨床檢查室研究產品以及銷售給商業實驗室和醫院的市售產品。檢測服務不包含在內。

該分析基於公司、政府和醫療組織的報告，並得到了文獻綜述以及對行業相關人員和體外診斷 (IVD) 專業人員的訪談的支持。

本報告的主要受眾

本報告對象為診斷設備製造商、組件和試劑供應商、投資者、業務拓展團隊和策略規劃人員。對於那些正在評估實驗室自動化、數位形態學或以患者為中心的形態學領域商機的人員來說，本報告尤其有用。

目錄

第1章摘要整理

  • 關於 Calorama 訊息
  • 血液學概述
  • 市場概覽
  • 調查方法

第2章：血液學概論及發展趨勢

  • 介紹
  • 數位影像分析
  • 數位化進程
  • 體外診斷血液學中的人工智慧
  • 品管測量程序

第3章：實驗室血液學檢查

  • 概述
  • 產品概述
  • 市場概況
  • 區域實驗室血液學檢測與設備市場

第4章：分佈式血液學檢測

  • 概述
  • 床邊檢測中的血紅素/血球比容
  • 去中心化（POC）市場概述
  • 區域性血液學檢測與設備市場

第5章 市場分析與主要供應商

  • 概要
  • 主要供應商
  • 中國和體外診斷血液學
  • 血液學檢測的商業性前景
簡介目錄
Product Code: 26-051KA

Global Laboratory-Based and Point-of-Care Hematology Market Forecast Through 2031

The complete blood count is one of the most frequently ordered tests in medicine, and the instruments that run it are changing faster than the test itself. Hematology is a mature IVD segment, but competition no longer centers only on cell counting. Vendors now compete on automation, digital morphology, AI-assisted cell classification and the ability to put full CBC testing outside the central laboratory. Worldwide Market for Hematology, 2026–2031 from Kalorama Information looks at where that shift creates revenue and which suppliers are positioned to capture it.

What the Report Covers

The report sizes and forecasts the global hematology testing market across two segments: laboratory-based hematology and decentralized (point-of-care) hematology. The laboratory segment is examined by vendor share, reagent sales by test type, and region. The decentralized segment is split into lab-style compact instruments and handheld devices. It also separates hemoglobin and hematocrit testing from other routine hematology performed near the patient.

Regional analysis covers North America, Europe, Asia Pacific and the Rest of World. For each region, the report breaks out laboratory and point-of-care sales.

Technology and Market Trends

The report examines the forces shaping purchasing decisions, including:

  • Digital morphology. The report covers the move from cell-gallery systems to full-field smear imaging, and the role of remote review in laboratory networks facing staffing shortages.
  • AI in hematology. Applications include flagging, specimen triage, autoverification and longitudinal result analysis. The report also covers the regulatory and validation limits on how quickly this software can change.
  • Decentralized testing. Cartridge-based and compact analyzers are taking CBC testing into oncology clinics, urgent care and physician offices. The report explains the practical difference between CLIA-waived and moderate-complexity systems.
  • Combined testing. Some analyzers pair the CBC with CRP, ESR or HbA1c measurement from a single specimen.

Competitive Analysis

The report provides vendor market shares for both laboratory and point-of-care segments, company revenue estimates, and a tiered view of the supplier base. Leading suppliers are profiled, including Sysmex, Beckman Coulter/Danaher, Mindray, Roche, Siemens Healthineers, Abbott, HORIBA and Nihon Kohden.

A dedicated section on China examines centralized procurement, payment reform, import substitution and the rise of domestic manufacturers. FDA registration and CLIA categorization trends are also analyzed. Product tables cover recent analyzer introductions, digital morphology systems, quality control products and point-of-care platforms.

Scope and Methodology

Market estimates are presented in U.S. dollars for 2026, with forecasts through 2031. Values are based on factory sales to the end user rather than retail pricing or reimbursement. The market includes analyzers, instruments and reagents sold for commercial laboratory and hospital use, some research-use products used in clinical laboratories, and over-the-counter products. Test services are excluded.

The analysis draws on company, government and medical organization reports, supported by literature searches and interviews with industry professionals and IVD experts.

Who Should Read This Report

This report is written for diagnostics manufacturers, component and reagent suppliers, investors, business development teams and strategic planners. It is especially relevant to anyone evaluating opportunities in laboratory automation, digital morphology or near-patient hematology.

Table of Contents

Chapter 1: Executive Summary

  • About Kalorama Information
  • Hematology Overview
  • Market Overview
    • Table 1-1: Global Hematology Testing Market, by Product Segment, 2026-2031 Est. (US$ millions) [Decentralized (POC) Hematology, Laboratory-based Hematology]
  • Scope and Methodology

Chapter 2: Overview of Hematology and Trends

  • Introduction
    • Figure 2-1: Hematology Analyzer Distribution of Sales by Menu Capability, 2026 Est. (%)
  • Digital Image Analysis
    • Table 2-1: CellaVision Market Share Data by Hematology Vendor, 2026 Est. (%)
    • Table 2-2: Selected Hematology Image Analysis Innovations
  • Digital Evolution
  • Artificial Intelligence in IVD Hematology
  • Quality Control Measurement Programs
    • Table 2-3: Selected Hematology Quality Control Products, 2026

Chapter 3: Laboratory-based Hematology Testing

  • Overview
  • Product Overview
    • Table 3-1: Selected Hematology Innovations, 2026
    • Table 3-2: Lab-Based Hematology Test and Instrument Market Share, by Vendor, 2026 Est. (%)
  • Market Summary
    • Table 3-3: Global Laboratory-based Hematology Test and Instrument Market, 2026 and 2031 (US$ millions)
    • Figure 3-1: Lab-based Hematology Sales by Reagent, 2026 Est. (%)
  • Regional Laboratory-based Hematology Test and Instrument Market
    • Table 3-4: Global Laboratory-based Hematology Test and Instrument Market, by Region, 2026 Est. (%)
    • Figure 3-2: Laboratory-based Hematology Test and Instrument Market, Regional Analysis, 2026 Est. (%)

Chapter 4: Decentralized Hematology Testing

  • Overview
  • Hemoglobin/Hematocrit at the POC
    • Table 4-1: POC Hematology Distribution by Specialty (Hematocrit/Hemoglobin vs. Other Routine Hematology), 2026 (%)
    • Table 4-2: Selected Hematocrit and Hemoglobin POC Systems, 2026
    • Table 4-3: Selected POC Hematology Analyzer Systems, 2026
    • Table 4-4: POC-Based Hematology Test and Instrument Market Share by Vendor, 2026 Est. (%)
  • Decentralized (POC) Market Summary
    • Table 4-5: Decentralized Hematology Test and Instrument Market, 2026 and 2031 Est. (US$ millions)
  • Regional Decentralized Hematology Test and Instrument Market
    • Table 4-6: Global Decentralized Hematology Test and Instrument Market, by Region, 2026 Est. (%)
    • Figure 4-1: Decentralized Hematology Test and Instrument Market, Regional Analysis, 2026 (%)

Chapter 5: Market Analysis & Leading Suppliers

  • Summary
    • Figure 5-1: Laboratory Hematology Analyzer CLIA Categorizations by Year, 2000–2026 YTD
    • Figure 5-2: FDA Registration Distribution by Company for Hematology Analyzers/Instruments (%)
    • Table 5-1: Hematology Market Revenue Distribution, by Product Type, 2026 Est. (%) [Analyzers, Instruments and Reagents]
    • Figure 5-3: Global Hematology Market Value, by Segment, 2026 Est. (US$ millions) [Laboratory-based and Decentralized (POC)]
    • Table 5-2: Global Hematology (Laboratory-based and POC) Sales Distribution, by Region, 2026 (%)
    • Figure 5-4: Global Hematology Market, by Testing Platform (Laboratory-based, POC) and Region, 2026 (US$ millions)
    • Figure 5-5: North America Hematology Market Revenue, Laboratory-Based vs. POC, 2026 (US$ millions)
    • Figure 5-6: North America Hematology Market Share, Laboratory-Based and POC Segments, 2026 (%)
    • Figure 5-7: Europe Hematology Market Revenue, Laboratory-Based vs. POC, 2026 (US$ millions)
    • Figure 5-8: Europe Hematology Market Share, Laboratory-Based vs. POC, 2026 (%)
    • Figure 5-9: Asia Pacific Hematology Market Revenue, Laboratory-Based vs. POC, 2026 (US$ millions)
    • Figure 5-10: Asia Pacific Hematology Market Share, Laboratory-Based vs. POC, 2026 (%)
    • Figure 5-11: Rest of World Hematology Market Revenue, Laboratory-Based vs. POC, 2026 (US$ millions)
    • Figure 5-12: Rest of World Hematology Market Share, Laboratory-Based vs. POC, 2026 (%)
  • Leading Suppliers
    • Table 5-3: Hematology, Company Revenues (laboratory and POC), 2026 Est. (US$ millions)
    • Table 5-4: Hematology Vendors (Laboratory, POC), 2026
  • China and IVD Hematology
  • The Commercial Outlook for Hematology Tests